Envestnet Asset Management Inc Cytosorbents Corp Transaction History

Envestnet Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$4.05 - $8.11 $52,382 - $104,894	-12,934 Closed	0 $0
Q3 2021 Oct 07, 2021	BUY	$7.0 - $9.71 $9,849 - $13,661	1,407 Added 12.21%	12,934 $105,000
Q2 2021 Aug 04, 2021	BUY	$7.55 - $9.42 $3,948 - $4,926	523 Added 4.75%	11,527 $87,000
Q1 2021 May 04, 2021	BUY	$8.23 - $11.48 $90,562 - $126,325	11,004 New	11,004 $96,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.